Please register here to receive the webinar link.

From Data to Discovery: Leveraging Systems Biology and AI to Accelerate Translational Medicine.

Led by Darya Orlova, CSO Intercellular Inc. who brings over 15 years of experience in computationaland translational biology. She specializes in biophysics, systems immunology, spatial and single-cell omics, and AI-enabled target and biomarker discovery, with extensive experience building production computational platforms and leading cross-functional research teams at organizations including Genentech, Cell Signaling Technology, and Stanford University. She is also a biotech founder: she co-founded Couloir Bio, which was acquired by Intercellular, and joined as CSO to lead the combined company's scientific vision.

About the webinar: In this webinar, Darya will explore how modern systems biology and AI can — and cannot — realistically contribute to the biopharmaceutical industry, from target discovery all the way through Phase IV, and what could meaningfully improve the odds of translational success. She will provide examples of how she is currently leveraging the merger of biostatistics, mechanistic modeling, and AI to contribute to translational medicine efforts.

This webinar will be hosted by SPARK Masaryk University (Czech Republic).